Murphy, R P <br/><br/>
Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  Jan 2000 
 - 266-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1079-5642 
<br/><br/><label>Standard No.: </label>10.1161/01.atv.20.1.266  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abortion, Habitual--blood<br/>Adult<br/>Alleles<br/>Base Sequence<br/>DNA Primers--genetics<br/>Enzyme Stability--genetics<br/>Factor V--genetics<br/>Female<br/>Gene Frequency<br/>Humans<br/>Methylenetetrahydrofolate Reductase (NADPH2)<br/>Mutation<br/>Oxidoreductases Acting on CH-NH Group Donors--genetics<br/>Polymorphism, Genetic<br/>Pregnancy<br/>Pregnancy Complications, Cardiovascular--blood<br/>Pregnancy Outcome<br/>Prospective Studies<br/>Risk Factors<br/>Temperature<br/>Thrombosis--blood